INTELLIPHARMACEUTICS

Intellipharmaceutics is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs... At Intellipharmaceutics, we are engaged in the research, development and commercialization of controlled-release and targeted pharmaceutical products, both novel and generic, with a particular emphasis in the opioid abuse deterrence space... Since our founding, we have expanded our premises twice and have amassed an array of core assets, including seven proprietary drug delivery technologies, over 70 issued and pending patents, and a growing pipeline of ANDA and NDA product candidates.

Also known as: Intellipharmaceutics International, Intellipharmaceutics International Inc.